1. Home
  2. BZH vs ARVN Comparison

BZH vs ARVN Comparison

Compare BZH & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$19.04

Market Cap

672.0M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$10.10

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZH
ARVN
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
672.0M
781.0M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
BZH
ARVN
Price
$19.04
$10.10
Analyst Decision
Strong Buy
Buy
Analyst Count
3
20
Target Price
$32.00
$15.35
AVG Volume (30 Days)
330.3K
670.7K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.84
EPS
N/A
N/A
Revenue
$2,087,739,000.00
$262,600,000.00
Revenue This Year
$4.36
N/A
Revenue Next Year
$10.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.37
$5.90
52 Week High
$28.33
$14.22

Technical Indicators

Market Signals
Indicator
BZH
ARVN
Relative Strength Index (RSI) 28.82 31.91
Support Level $18.93 $9.02
Resistance Level $23.75 $10.18
Average True Range (ATR) 0.67 0.67
MACD -0.12 -0.22
Stochastic Oscillator 13.47 4.18

Price Performance

Historical Comparison
BZH
ARVN

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: